This symposium brings together clinicians, physicists, and researchers in a collaborative forum to explore the expanding role of radiation therapy in treating benign diseases. It will highlight emerging evidence, innovative techniques, and provide a multidisciplinary perspective on the topic.
Attendance Options
In-Person Fred & Pamela Buffett Cancer Center – Rm 0.12.101 505 S 45th Street, Omaha, NE 68105
Live Stream Via Zoom – Instructions on how to join the live stream will be sent to registered participants via email a few days before the start of the symposium.
At the conclusion of this activity, the participants should be better able to:
Identify the benign conditions for which radiation therapy (RT) is an appropriate treatment option and compare RT with surgical and medical alternatives.
Describe modern radiation techniques—including stereotactic radiosurgery (SRS), and proton therapy—for treating benign diseases with high precision and minimal toxicity.
Review the radiobiologic principles and dose–response relationships specific to benign tissue targets, including implications for hypo- or ultra-hypofractionation (e.g., FLASH RT).
Evaluate treatment outcomes, quality-of-life metrics, and long-term safety data for RT in benign disease contexts.
Apply evidence-based criteria for patient selection, treatment planning, and follow-up in the use of RT for benign diseases such as vestibular schwannoma, thyroid eye disease, and osteoarthritis.
Discuss the role of multidisciplinary collaboration—including neurosurgery, ophthalmology, cardiology, orthopedics, and rehabilitation—in the management of benign conditions using RT.
Discuss the evolving regulatory, ethical, and reimbursement considerations for RT in non-malignant indications.
Explore future directions and ongoing research, including proton FLASH therapy and digital twin modeling in radiation therapy for benign disease.
This accredited continuing education activity is designed for physicians, medical physicists, radiation therapists, dosimetrists, nurses, fellows, residents, and students.
In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The University of Nebraska Medical Center designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The University of Nebraska Medical Center designates this activity for up to 16.5 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Others
Commission on Accreditation of Medical Physics Education Program (CAMPEP), American Society of Radiologic Technologists (ASRT), and Medical Dosimetrist Certification Board (MDCB) credits will also be available.
Registration Information
General Registration
By July 25
Starting July 26
Aug. 22-23
$100
$150
Aug. 22 Only
$65
$100
Aug. 23 Only
$65
$100
Registration Information
Fellows/Residents/Students
Fellows, residents, and students may attend this symposium for free.
If you need assistance with online registration, please call our Registration Office at 402-559-5929.
Cancel/Refund Policy
If you need to cancel your registration, please email registrationCCE@unmc.edu no later than Aug. 15, 2025. There is a $25 processing fee for cancellations made by Aug. 15. Cancellations made after this date and registrants who fail to attend are responsible for the full registration fee.
Symposium Director
Chi Lin, MD, PhD
Professor and Vice Chair of Research, Department of Radiation Oncology, UNMC
Questions?
Missy Edwards
Educational Projects Coordinator, Center for Continuing Education, UNMC
Friday-Saturday, Aug. 22–23
